SCOLR controlled-delivery drugs
This article was originally published in The Tan Sheet
Executive Summary
SCOLR Pharma plans to develop 24-hour OTC pseudoephedrine decongestant and12-hour OTC combination ibuprofen/pseudoephedrine cough/cold products using the company's controlled delivery technology (CDT) platform, the firm says April 13. All three products are in the preclinical stages of development. The Bellevue, Wash.-based firm recently announced positive results from trials on 12-hour CDT pseudoephedrine and ibuprofen products and intends to submit both for FDA approval this summer (1"The Tan Sheet" April 4, 2005, p. 15)...
SCOLR Pharma plans to develop 24-hour OTC pseudoephedrine decongestant and12-hour OTC combination ibuprofen/pseudoephedrine cough/cold products using the company's controlled delivery technology (CDT) platform, the firm says April 13. All three products are in the preclinical stages of development. The Bellevue, Wash.-based firm recently announced positive results from trials on 12-hour CDT pseudoephedrine and ibuprofen products and intends to submit both for FDA approval this summer (1 (Also see "Extended-Release Pseudoephedrine Trial Results “Positive,” SCOLR Says" - Pink Sheet, 4 Apr, 2005.), p. 15).... |